1. Home
  2. VTYX vs MYFW Comparison

VTYX vs MYFW Comparison

Compare VTYX & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • MYFW
  • Stock Information
  • Founded
  • VTYX 2018
  • MYFW 2002
  • Country
  • VTYX United States
  • MYFW United States
  • Employees
  • VTYX N/A
  • MYFW N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • MYFW Major Banks
  • Sector
  • VTYX Health Care
  • MYFW Finance
  • Exchange
  • VTYX Nasdaq
  • MYFW Nasdaq
  • Market Cap
  • VTYX 154.9M
  • MYFW 170.9M
  • IPO Year
  • VTYX 2021
  • MYFW 2018
  • Fundamental
  • Price
  • VTYX $1.61
  • MYFW $19.57
  • Analyst Decision
  • VTYX Buy
  • MYFW Buy
  • Analyst Count
  • VTYX 4
  • MYFW 3
  • Target Price
  • VTYX $11.33
  • MYFW $21.83
  • AVG Volume (30 Days)
  • VTYX 1.3M
  • MYFW 26.6K
  • Earning Date
  • VTYX 03-04-2025
  • MYFW 04-17-2025
  • Dividend Yield
  • VTYX N/A
  • MYFW N/A
  • EPS Growth
  • VTYX N/A
  • MYFW N/A
  • EPS
  • VTYX N/A
  • MYFW 0.26
  • Revenue
  • VTYX N/A
  • MYFW $79,649,000.00
  • Revenue This Year
  • VTYX N/A
  • MYFW N/A
  • Revenue Next Year
  • VTYX N/A
  • MYFW $10.84
  • P/E Ratio
  • VTYX N/A
  • MYFW $75.18
  • Revenue Growth
  • VTYX N/A
  • MYFW N/A
  • 52 Week Low
  • VTYX $1.57
  • MYFW $12.84
  • 52 Week High
  • VTYX $11.48
  • MYFW $22.32
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 34.49
  • MYFW 42.09
  • Support Level
  • VTYX $1.57
  • MYFW $20.60
  • Resistance Level
  • VTYX $1.78
  • MYFW $21.70
  • Average True Range (ATR)
  • VTYX 0.10
  • MYFW 0.62
  • MACD
  • VTYX -0.00
  • MYFW -0.16
  • Stochastic Oscillator
  • VTYX 10.26
  • MYFW 2.80

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

Share on Social Networks: